Skip to content

Drug interactions

Axicabtagene ciloleucel + Ifosfamide

Severity: Major

Axicabtagene ciloleucel and Ifosfamide: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ifosfamide is myelosuppressive and immunosuppressive, and axicabtagene ciloleucel can cause prolonged cytopenias and infection risk. Concurrent use may add to infection risk and impair CAR-T cell collection or expansion.

What this interaction means in plain words

Axicabtagene ciloleucel and Ifosfamide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Axicabtagene ciloleucel belongs to Oncology; Ifosfamide belongs to Oncology.

Evidence level: Low

Why it happens

Additive immunosuppression and myelosuppression; cytotoxic therapy may reduce CAR-T cell expansion.

What to do

Avoid chemotherapy other than planned lymphodepletion around CAR-T infusion and observe the washout before leukapheresis. Monitor blood counts and infection afterwards.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Axicabtagene ciloleucel and Ifosfamide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Axicabtagene ciloleucel with Ifosfamide?

MediHelp rates the interaction as major. Axicabtagene ciloleucel and Ifosfamide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Ifosfamide is myelosuppressive and immunosuppressive, and axicabtagene ciloleucel can cause prolonged cytopenias and infection risk. Concurrent use may add to infection risk and impair CAR-T cell collection or expansion.

How serious is the interaction between Axicabtagene ciloleucel and Ifosfamide?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid chemotherapy other than planned lymphodepletion around CAR-T infusion and observe the washout before leukapheresis. Monitor blood counts and infection afterwards.

What other medicines interact with Ifosfamide?

MediHelp also lists interactions of Ifosfamide with, for example, Adenovirus types 4 and 7 live, Measles mumps and rubella vaccine, Measles mumps and rubella vaccine live. The full list is on the Ifosfamide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in